3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Vomiting
13
Nausea
11
Neoplasms
3
Leukemia, Myeloid, Acute
2
Carcinoma, Non-Small-Cell Lung
2
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Radiation Injuries
1
Pruritus
1
Postoperative Nausea and Vomiting
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
ITCH
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Bile Duct Neoplasms
1
Interventions
desloratadine
1
Aprepitant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pruritus
×
Aprepitant
×
Clear all
NCT02646020
2021-05-18
EGFR-TKIs
Sun Yat-sen University
Phase 2
Completed
138 enrolled